Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Myocilin ELISA Kit (AC3559)
Cat.#: ASET-2148
Specifications
Description Human Myocilin ELISA Kit allows for the in vitro quantitative determination of human Myocilin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2231 Human Dystrophin ELISA Kit (AC3642) Quantitative inquiry ASET-1342 Mouse Prokineticin Receptor 1 ELISA Kit (AC2753) Quantitative inquiry ASET-1729 Rabbit FGF2 ELISA Kit (AC3140) Quantitative inquiry ASET-2363 Human GFAP ELISA Kit (AC3774) Quantitative inquiry ASET-1042 Human Pannexin 1 ELISA Kit (AC2453) Quantitative inquiry ASET-1608 Mouse LRP5 ELISA Kit (AC3019) Quantitative inquiry ASET-1233 Human TAS2R38 ELISA Kit (AC2644) Quantitative inquiry ASET-2190 Human KIAA1199 ELISA Kit (AC3601) Quantitative inquiry ASET-1323 Rat Glutamine Synthetase ELISA Kit (AC2734) Quantitative inquiry ASET-1284 Human alpha B Crystallin ELISA Kit (AC2695) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket